Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • anglabat
    Junior Member
    • Dec 2013
    • 1

    #1

    Deconvolving RNAseq data

    Hi,

    I'm trying to deconvolve RNAseq data derived from mixed blood leukocytes by known cell proportions. Some of this data comes from model organisms, but other data comes from rare species. As such, I'm having difficulty applying any method that requires a matrix of expression levels of known cell type biomarkers. The way I see it, I have two choices

    1) deconvolve everyone based on data for one model organism and discuss the data in that specific light. In this case I need to be pointed to a dataset/database of blood cell-specific biomarkers for human or mouse.

    2) deconvolve using some other method that can use my known proportions, does not require me to add a matrix of biomarker expression.

    I'm very new to this technology. Please forgive my ignorance. I'm happy for any advice.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Have you considered just doing ICA? Particularly if you know approximately how many cell-types there are then that should be relatively straight forward.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...